Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Michael A Walker

Showing results (31-40 of 35) with videos related to

Pageof 4
Sort By:
You have reached the last page of results.This site can display upto 35 results.
Bioorganic & Medicinal Chemistry Letters|December 23, 2014
Synthesis and evaluation of C2-carbon-linked heterocyclic-5-hydroxy-6-oxo-dihydropyrimidine-4-carboxamides as HIV-1 integrase inhibitorsB Narasimhulu Naidu, Margaret E Sorenson, Manoj Patel, et al.
Bioorganic & Medicinal Chemistry Letters|May 22, 2018
The discovery and preclinical evaluation of BMS-707035, a potent HIV-1 integrase strand transfer inhibitorB Narasimhulu Naidu, Michael A Walker, Margaret E Sorenson, et al.
Journal of Medicinal Chemistry|February 22, 2020
Discovery and Optimization of Novel Pyrazolopyrimidines as Potent and Orally Bioavailable Allosteric HIV-1 Integrase InhibitorsGuo Li, Nicholas A Meanwell, Mark R Krystal, et al.
Journal of Medicinal Chemistry|January 5, 2019
5,6,7,8-Tetrahydro-1,6-naphthyridine Derivatives as Potent HIV-1-Integrase-Allosteric-Site InhibitorsKevin M Peese, Christopher W Allard, Timothy Connolly, et al.
ACS Medicinal Chemistry Letters|June 16, 2022
Discovery and Preclinical Profiling of GSK3839919, a Potent HIV-1 Allosteric Integrase InhibitorKyle Parcella, Tao Wang, Kyle Eastman, et al.
Pageof 4

Showing results (31-40 of 35) with videos related to

Sort By:
Pageof 4
You have reached the last page of results.This site can display upto 35 results.
Bioorganic & Medicinal Chemistry Letters|December 23, 2014
Synthesis and evaluation of C2-carbon-linked heterocyclic-5-hydroxy-6-oxo-dihydropyrimidine-4-carboxamides as HIV-1 integrase inhibitorsB Narasimhulu Naidu, Margaret E Sorenson, Manoj Patel, et al.
Bioorganic & Medicinal Chemistry Letters|May 22, 2018
The discovery and preclinical evaluation of BMS-707035, a potent HIV-1 integrase strand transfer inhibitorB Narasimhulu Naidu, Michael A Walker, Margaret E Sorenson, et al.
Journal of Medicinal Chemistry|February 22, 2020
Discovery and Optimization of Novel Pyrazolopyrimidines as Potent and Orally Bioavailable Allosteric HIV-1 Integrase InhibitorsGuo Li, Nicholas A Meanwell, Mark R Krystal, et al.
Journal of Medicinal Chemistry|January 5, 2019
5,6,7,8-Tetrahydro-1,6-naphthyridine Derivatives as Potent HIV-1-Integrase-Allosteric-Site InhibitorsKevin M Peese, Christopher W Allard, Timothy Connolly, et al.
ACS Medicinal Chemistry Letters|June 16, 2022
Discovery and Preclinical Profiling of GSK3839919, a Potent HIV-1 Allosteric Integrase InhibitorKyle Parcella, Tao Wang, Kyle Eastman, et al.
Pageof 4